Annual Cost Of Goods Sold
$1.57 B
+$145.45 M+10.19%
31 December 2023
Summary:
Amneal Pharmaceuticals annual cost of goods sold is currently $1.57 billion, with the most recent change of +$145.45 million (+10.19%) on 31 December 2023. During the last 3 years, it has risen by +$208.91 million (+15.31%). AMRX annual cost of goods sold is now at all-time high.AMRX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$432.91 M
-$18.92 M-4.19%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly cost of goods sold is currently $432.91 million, with the most recent change of -$18.92 million (-4.19%) on 30 September 2024. Over the past year, it has increased by +$45.40 million (+11.72%). AMRX quarterly cost of goods sold is now -4.19% below its all-time high of $451.83 million, reached on 30 June 2024.AMRX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$1.73 B
+$45.40 M+2.69%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM cost of goods sold is currently $1.73 billion, with the most recent change of +$45.40 million (+2.69%) on 30 September 2024. Over the past year, it has increased by +$192.77 million (+12.52%). AMRX TTM cost of goods sold is now at all-time high.AMRX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.2% | +11.7% | +12.5% |
| 3 y3 years | +15.3% | +31.1% | +33.6% |
| 5 y5 years | +66.2% | +33.7% | +34.3% |
AMRX Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +18.8% | -4.2% | +34.0% | at high | +33.6% |
| 5 y | 5 years | at high | +66.2% | -4.2% | +50.8% | at high | +41.4% |
| alltime | all time | at high | +273.9% | -4.2% | +261.6% | at high | +1173.0% |
Amneal Pharmaceuticals Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $432.91 M(-4.2%) | $1.73 B(+2.7%) |
| June 2024 | - | $451.83 M(+7.3%) | $1.69 B(+4.5%) |
| Mar 2024 | - | $421.13 M(-1.4%) | $1.61 B(+2.7%) |
| Dec 2023 | $1.57 B(+10.2%) | $427.15 M(+10.2%) | $1.57 B(+2.1%) |
| Sept 2023 | - | $387.51 M(+2.2%) | $1.54 B(+2.4%) |
| June 2023 | - | $379.02 M(-0.1%) | $1.50 B(+1.4%) |
| Mar 2023 | - | $379.35 M(-3.8%) | $1.48 B(+3.9%) |
| Dec 2022 | $1.43 B(+7.8%) | $394.37 M(+12.3%) | $1.43 B(+1.7%) |
| Sept 2022 | - | $351.33 M(-2.1%) | $1.40 B(+1.5%) |
| June 2022 | - | $358.84 M(+11.1%) | $1.38 B(+2.7%) |
| Mar 2022 | - | $323.06 M(-12.8%) | $1.35 B(+1.6%) |
| Dec 2021 | $1.32 B(-2.9%) | $370.49 M(+12.2%) | $1.32 B(+2.1%) |
| Sept 2021 | - | $330.08 M(+2.3%) | $1.30 B(-4.1%) |
| June 2021 | - | $322.58 M(+7.0%) | $1.35 B(+0.2%) |
| Mar 2021 | - | $301.54 M(-12.1%) | $1.35 B(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $1.36 B(+7.1%) | $342.96 M(-11.1%) | $1.36 B(+4.3%) |
| Sept 2020 | - | $385.71 M(+20.4%) | $1.31 B(+5.0%) |
| June 2020 | - | $320.43 M(+1.7%) | $1.25 B(+1.7%) |
| Mar 2020 | - | $315.03 M(+9.7%) | $1.23 B(-3.8%) |
| Dec 2019 | $1.27 B(+34.5%) | $287.09 M(-11.3%) | $1.27 B(-1.3%) |
| Sept 2019 | - | $323.85 M(+8.2%) | $1.29 B(+3.8%) |
| June 2019 | - | $299.39 M(-17.5%) | $1.24 B(+5.4%) |
| Mar 2019 | - | $363.04 M(+19.4%) | $1.18 B(+24.6%) |
| Dec 2018 | $946.59 M(+86.5%) | $304.12 M(+10.0%) | $946.59 M(+20.7%) |
| Sept 2018 | - | $276.38 M(+17.4%) | $784.42 M(+25.0%) |
| June 2018 | - | $235.49 M(+80.3%) | $627.76 M(+18.8%) |
| Mar 2018 | - | $130.59 M(-8.0%) | $528.40 M(+32.8%) |
| Dec 2017 | $507.48 M(+20.6%) | $141.95 M(+18.6%) | $397.81 M(+55.5%) |
| Sept 2017 | - | $119.72 M(-12.1%) | $255.86 M(+87.9%) |
| June 2017 | - | $136.14 M | $136.14 M |
| Dec 2016 | $420.77 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual cost of goods sold?
- What is the all time high annual cost of goods sold for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual cost of goods sold year-on-year change?
- What is Amneal Pharmaceuticals quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly cost of goods sold year-on-year change?
- What is Amneal Pharmaceuticals TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM cost of goods sold year-on-year change?
What is Amneal Pharmaceuticals annual cost of goods sold?
The current annual cost of goods sold of AMRX is $1.57 B
What is the all time high annual cost of goods sold for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual cost of goods sold is $1.57 B
What is Amneal Pharmaceuticals annual cost of goods sold year-on-year change?
Over the past year, AMRX annual cost of goods sold has changed by +$145.45 M (+10.19%)
What is Amneal Pharmaceuticals quarterly cost of goods sold?
The current quarterly cost of goods sold of AMRX is $432.91 M
What is the all time high quarterly cost of goods sold for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly cost of goods sold is $451.83 M
What is Amneal Pharmaceuticals quarterly cost of goods sold year-on-year change?
Over the past year, AMRX quarterly cost of goods sold has changed by +$45.40 M (+11.72%)
What is Amneal Pharmaceuticals TTM cost of goods sold?
The current TTM cost of goods sold of AMRX is $1.73 B
What is the all time high TTM cost of goods sold for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM cost of goods sold is $1.73 B
What is Amneal Pharmaceuticals TTM cost of goods sold year-on-year change?
Over the past year, AMRX TTM cost of goods sold has changed by +$192.77 M (+12.52%)